0.55
-0.0047(-0.85%)
Currency In USD
| Previous Close | 0.55 |
| Open | 0.56 |
| Day High | 0.56 |
| Day Low | 0.54 |
| 52-Week High | 3.75 |
| 52-Week Low | 0.39 |
| Volume | 555,975 |
| Average Volume | 1.83M |
| Market Cap | 40.08M |
| PE | -0.61 |
| EPS | -0.9 |
| Moving Average 50 Days | 0.53 |
| Moving Average 200 Days | 1.22 |
| Change | -0 |
If you invested $1000 in Rani Therapeutics Holdings, Inc. (RANI) since IPO date, it would be worth $49.92 as of August 20, 2025 at a share price of $0.549. Whereas If you bought $1000 worth of Rani Therapeutics Holdings, Inc. (RANI) shares 3 years ago, it would be worth $50.84 as of August 20, 2025 at a share price of $0.549.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering
GlobeNewswire Inc.
Jul 15, 2025 1:00 PM GMT
SAN JOSE, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that
Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery
GlobeNewswire Inc.
Jul 14, 2025 9:00 AM GMT
SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that
Rani Therapeutics Announces Research Agreement with Chugai
GlobeNewswire Inc.
May 19, 2025 12:00 PM GMT
- Research agreement is evaluating feasibility of applying Rani’s oral delivery technology to Chugai’s antibodies against undisclosed targets - SAN JOSE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics